Filing Details

Accession Number:
0001181431-11-056256
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-11-15 17:04:09
Reporting Period:
2011-11-11
Filing Date:
2011-11-15
Accepted Time:
2011-11-15 17:04:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
891288 Questcor Pharmaceuticals Inc QCOR Pharmaceutical Preparations (2834) 330476164
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1326104 Jeffrey David Medeiros 1300 North Kellogg Drive
Suite D
Anaheim CA 92807
Senior Vp, Pharm. Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-11-11 104,806 $0.98 112,245 No 4 M Direct
Common Stock Acquisiton 2011-11-11 18,230 $0.44 130,475 No 4 M Direct
Common Stock Disposition 2011-11-11 123,036 $42.98 7,439 No 4 S Direct
Common Stock Acquisiton 2011-11-14 10,000 $1.37 17,439 No 4 M Direct
Common Stock Acquisiton 2011-11-14 40,572 $1.37 58,011 No 4 M Direct
Common Stock Disposition 2011-11-14 50,572 $43.99 7,439 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2011-11-11 104,806 $0.00 104,806 $0.98
Common Stock Stock Option (Right to Buy) Disposition 2011-11-11 18,230 $0.00 18,230 $0.44
Common Stock Stock Option (Right to Buy) Disposition 2011-11-14 10,000 $0.00 10,000 $1.37
Common Stock Stock Option (Right to Buy) Disposition 2011-11-14 40,572 $0.00 40,572 $1.37
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-02-26 No 4 M Direct
0 2014-09-16 No 4 M Direct
14,258 2017-02-08 No 4 M Direct
75,170 2017-02-08 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.90-$43.14, inclusive. The reporting person undertakes to provide Questcor Pharmaceuticals, Inc., any security holder of Questcor Pharmkaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 1 of the Form 4.
  2. Incentive Stock option granted under the Questcor Pharmaceuticals, Inc. 1992 Employee Stock Option Plan on February 27, 2006.
  3. The option was fully vested and exercisable as of February 27, 2010.
  4. Incentive Stock option granted under the Questcor Pharmaceuticals, Inc. 1992 Employee Stock Option Plan on September 17, 2004.
  5. The option was fully vested and exercisable as of September 17, 2008.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.95-$44.10, inclusive. The reporting person undertakes to provide Questcor Pharmaceuticals, Inc., any security holder of Questcor Pharmkaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 6 of the Form 4.
  7. Non-Qualified Stock options granted under the Questcor Pharmaceuticals, Inc. 2006 Equity Incentive Award Plan on February 9, 2007.
  8. The option was fully vested and exercisable as of December 9, 2008.
  9. Incentive Stock option granted under the Questcor Pharmaceuticals, Inc. 2006 Equity Incentive Award Plan on February 9, 2007.
  10. The option was fully vested and exercisable as of February 9, 2011.